Skip to main content
$100M shelf registration filed by Cancer Genetics

A shelf registration has been filed by Cancer Genetics with the SEC for an offering of up to $100 million in common stock, warrants, preferred stock and overallotment purchase rights and units. The company intends to use the net proceeds as working capital, as well as to support its other general corporate functions.

Full Story: